Sanofi India jumps on Q4 revenue growth
** Sanofi India SANO.NS jumps ~5% to 6,343 rupees; set for fifth consecutive day of gains ** Co's Q4 revenue up 5% y/y, total expenses down 2.4% on strong operational performance ** Growth driven by new-age insulin brand Toujeo and probiotic supplement enterogermina - ICICI Securities ** More than 37,000 shares traded, 1.8x 30 day average volume ** YTD, SANO up 3.5%, with ~10% jump in five sessions (Reporting by Vivek Kumar M) ((VivekKumar.M@thomsonreuters.com;))
Recent news on Sanofi India
See all newsSanofi India gains as quarterly profit doubles on strong diabetes business performance
Brief: Sanofi India Sept-Quarter Profit 1.17 Billion Rupees
Brief: Sanofi India Gets Tax Notice Worth 164 Million Rupees
Brief: Sanofi India Says Supreme Court Of India Has Dismissed Co's Petition Seeking Quashing Of Criminal Proceedings
Brief: Sanofi India Says Tax Demand Of 7.3 Million Rupees Vacated For AY 2019-20